Efficacy and safety of glatiramer acetate in multiple sclerosis patients with allergic respiratory diseases

被引：0
作者：
Mallucci, G.
La Mantia, L.
Confalonieri, P. A.
Galgani, S.
Haggiag, S.
Lugaresi, A.
De Luca, G.
Solaro, C.
Trabucco, E.
Meola, G.
Robotti, M.
Cavaletti, G.
Frigeni, B.
Clerici, R.
Chiveri, L.
Bono, G.
Banfi, P.
Ambrosoni, E.
Mancardi, L.
Della Cava, F.
Balgera, R.
Bergamaschi, R.
机构：
[1] Fdn Ist Neurol Nazl C Mondino IRCCS, Pavia, Italy
[2] Fdn IRCCS Ist Neurol Carlo Besta, Milan, Italy
[3] Azienda Osped San Camillo Forlanini, Rome, Italy
[4] Policlin SS Annunziata, Chieti, Italy
[5] ASL3 Genovese, Genoa, Italy
[6] IRCCS Policlin San Donato, Milan, Italy
[7] Azienda Osped San Gerardo, Monza, Italy
[8] Osped Valduce, Como, Italy
[9] Osped Circolo Varese, Varese, Italy
[10] Fdn Macchi, Varese, Italy
[11] IRCCS Azienda Osped Univ San Martino, Genoa, Italy
[12] Azienda Osped Prov Lecco, Lecce, Italy
来源：
MULTIPLE SCLEROSIS JOURNAL | 2012年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：428 / 429
页数：2
相关论文
共 50 条
[21]   Metabolic response to glatiramer acetate therapy in multiple sclerosis patients [J].
De Riccardis, Lidia ;
Ferramosca, Alessandra ;
Danieli, Antonio ;
Trianni, Giorgio ;
Zara, Vincenzo ;
De Robertis, Francesca ;
Maffia, Michele .
BBA CLINICAL, 2016, 6 :131-137
[22]   Glatiramer acetate to treat multiple sclerosis during pregnancy and lactation: a safety evaluation [J].
Fragoso, Yara Dadalti .
EXPERT OPINION ON DRUG SAFETY, 2014, 13 (12) :1743-1748
[23]   Glatiramer acetate: Mechanisms of action in multiple sclerosis [J].
Ziemssen, Tjalf ;
Schrempf, Wiebke .
NEUROBIOLOGY OF MULTIPLE SCLEROSIS, 2007, 79 :537-570
[24]   Glatiramer acetate depot (extended-release) phase iia study in patients with primary progressive multiple sclerosis: safety and efficacy snapshot [J].
Flechter, S. ;
Popper, L. ;
Kimelman, N. Bleich ;
Demender, I. ;
Rubnov, S. ;
Danon, U. ;
Marom, E. ;
Milo, R. ;
Gilad, R. ;
Weller, B. ;
Vaknin-Dembinsky, A. ;
Hellmann, M. ;
Karni, A. .
MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) :89-89
[25]   Is glatiramer acetate better for pregnancy in multiple sclerosis? [J].
Kasatkin, D. S. ;
Vinogradova, T. V. ;
Shitova, A. S. ;
Spirin, N. N. .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2015, 357 :E307-E308
[26]   Glatiramer acetate (Copaxone®) therapy for multiple sclerosis [J].
Dhib-Jalbut, S .
PHARMACOLOGY & THERAPEUTICS, 2003, 98 (02) :245-255
[27]   Glatiramer acetate depot (extended-release) phase IIa study in patients with primary progressive multiple sclerosis: safety and efficacy snapshot [J].
Flechter, S. ;
Popper, L. ;
Kimelman, N. Bleich ;
Demender, I. ;
Rubnov, S. ;
Danon, U. ;
Marom, E. ;
Milo, R. ;
Gilad, R. ;
Weller, B. ;
Vaknin-Dembinsky, A. ;
Hellmann, M. ;
Shifrin, A. ;
Karni, A. .
MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) :591-591
[28]   Glatiramer Acetate Depot (extended-release) phase IIa study in patients with primary progressive multiple sclerosis: safety and efficacy snapshot [J].
Flechter, Shlomo ;
Popper, Laura ;
Kimelman, Nadav Bleich ;
Demender, Inna ;
Rubnov, Shai ;
Danon, Uri ;
Marom, Ehud ;
Milo, Ron ;
Gilad, Ronit ;
Weller, Boaz ;
Vaknin-Dembinsky, Adi ;
Hellmann, Mark ;
Karni, Arnon .
NEUROLOGY, 2020, 94 (15)
[29]   Evidence for use of glatiramer acetate in multiple sclerosis [J].
Caramanos, Z ;
Arnold, DL .
LANCET NEUROLOGY, 2005, 4 (02) :74-75
[30]   Monitoring Glatiramer Acetate treatment in multiple sclerosis [J].
Farina, C ;
Hohlfeld, R .
NEUROLOGY, 2002, 58 (07) :A246-A246
12345